Fenofibrate Augments the Sensitivity of Drug-Resistant Prostate Cancer Cells to Docetaxel

Fenofibrate Augments the Sensitivity of Drug-Resistant Prostate Cancer Cells to Docetaxel

Metronomic agents reduce the effective doses and adverse effects of cytostatics in cancer chemotherapy. Therefore, they can enhance the treatment efficiency of drug-resistant cancers. Cytostatic and anti-angiogenic effects of fenofibrate (FF) suggest that it can be used for the metronomic chemothera...

Full description

Bibliographic Details
Main Authors: Marcin Luty, Katarzyna Piwowarczyk, Anna Łabędź-Masłowska, Tomasz Wróbel, Małgorzata Szczygieł, Jessica Catapano, Grażyna Drabik, Damian Ryszawy, Sylwia Kędracka-Krok, Zbigniew Madeja, Maciej Siedlar, Martyna Elas, Jarosław Czyż
Format: Article
Language:English
Published: MDPI AG 2019-01-01
Series:Cancers
Subjects:
fenofibrate
chemotherapy
prostate cancer
drug-resistance
cancer microevolution
Online Access:http://www.mdpi.com/2072-6694/11/1/77

Internet

http://www.mdpi.com/2072-6694/11/1/77

Similar Items